Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer

Journal of Clinical Oncology

Volumn 16, Issue 10, 1998, Pages 3406-3411

  Benevolo, Maria ^a   Mottolese, Marcella ^a   Cosimelli, Maurizio ^a   Tedesco, Manfredo ^a   Giannarelli, Diana ^a   Vasselli, Stefania ^a   Carlini, Massimo ^a   Garofalo, Alfredo ^a   Natali, Pier Giorgio ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AR3; MONOCLONAL ANTIBODY B.72.3; MONOCLONAL ANTIBODY BD5; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEUM LAVAGE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

EID: 0031759840     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.10.3406     Document Type: Article

References (29)

1. Koga S, Kaibara N, Litsuka Y, et al: Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients. J Cancer Res Clin Oncol 108:236-238, 1984
2. Boku T, Nakane Y, Minoura T, et al: Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 77:436-439, 1990
3. Nakajima T, Harashima S, Hirata M, et al: Prognostic and therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol 22:225-229, 1978
4. Martin JK, Goellner JR: Abdominal fluid cytology in patients with gastrointestinal malignant lesions. Mayo Clin Proc 61:467-471, 1986
5. Jaehne J, Meyer HJ, Soudah B, et al: Peritoneal lavage in gastric carcinoma. Dig Surg 6:26-28, 1989
6. Sendler A, Dittler HJ, Feussner H, et al: Preoperative staging of gastric cancer as precondition for multimodal treatment. World J Surg 19:501-508, 1995
7. Mottolese M, Salzano M, Vincenzoni C, et al: The use of a panel of monoclonal antibodies can lower false-negative diagnoses of peritoneal washings in ovarian tumors. Cancer 68:1803-1807, 1991
8. Leong ASY: Immunostaining of cytologic specimens. Am J Clin Pathol 105:139-140, 1996
9. Pantel K, Izbicki JR, Angstwurm M, et al: Immunocytological detection of bone marrow micrometastases in operable non-small-cell lung cancer. Cancer Res 53:1027-1031, 1993
10. Nekarda H, Schenck U, Ludwig C, et al: Prognosis of free abdominal cancer cells in totally resected gastric cancer. Eur J Surg Oncol 20:361, 1994 (abstr)
11. Juhl H, Stritzel M, Wroblewski A, et al: Immunocytochemical detection of micrometastatic cells: Comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 57:330-335, 1994
12. Ohuchi N, Thor A, Nose M, et al: Tumor-associated glycoprotein (TAG-72) detected in adenocarcinomas and benign lesions of the stomach. Int J Cancer 38:643-650, 1986
13. Prat M, Morra I, Bussolati G, et al: CAR-3, a monoclonal antibody-defined antigen expressed on human carcinomas. Cancer Res 45:5799-5807, 1985
14. Prat M, Rossino P, Bussolati G, et al: Production of monoclonal antibodies for the immunohistochemical detection of gastric carcinomas. Cancer Detect Prev 10:293-301, 1987
15. Eliaszin M, Donner A: Application of the McNemar test to non-independent matched pair data. Stat Med 10:1981-1991, 1991
16. Mottolese M, Venturo I, Salzano M, et al: Immunocytodiagnosis of solid tumors employing panels of monoclonal antibodies. J Clin Lab Anal 7:238-242, 1993
17. Ravinsky E: Cytology of peritoneal washings in gynaecological patients. Acta Cytol 30:8-16, 1986
18. Maruyama K: The most important prognostic factors for gastric cancer patients. A study using univariate and multivariate analysis. Scand J Gastroenterol 22:563-68, 1987
19. Yu CCW, Levison DA, Dunn JA, et al: Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. Br J Cancer 71:1106-1110, 1995
20. Davessar K, Pezzullo JC, Kessimian N, et al: Gastric adenocarcinoma: Prognostic significance of several pathologic parameters and histological classifications. Hum Pathol 21:325-332, 1990
21. Setala LP, Kosma VM, Marin S, et al: Prognostic factors in gastric cancer: The value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer 74:766-772, 1996
22. Abe S, Yoshimura H, Tabara H, et al: Curative resection of gastric cancer: Limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol 59:226-229, 1995
23. Mottolese M, Venturo I, Perrone Donnorso R, et al: Use of selected combinations of MoAbs to TAA in the diagnosis of neoplastic effusions of unknown origin. Eur J Cancer Clin Oncol 24:1277-1284, 1988
24. Iitsuka Y, Kaneshima S, Tanida O, et al: Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 44:1476-1480, 1979
25. Abe M, Nishimura Y, Shibamoto Y: Intraoperative radiation therapy for gastric cancer. World J Surg 19:544-547, 1995
26. Koga S, Hamazoe R, Maeta M, et al: Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 61:232-237, 1988
27. Cavaliere F, Cosimelli M, Civalleri D, et al: Postoperative intraperitoneal chemotherapy as adjuvant treatment of resectable gastric cancer. Reg Cancer Treat 4:199-203, 1993
28. Tsujitani S, Okuyama T, Watanabe A, et al: Intraperitoneal cisplatin during surgery for gastric cancer and peritoneal seeding. Anticancer Res 13:1831-1834, 1993
29. Hamazoe R, Maeta M, Kaibara N: Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer 73:2048-2052, 1994